tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Jenscare Scientific Co., Ltd. Announces 2025 Extraordinary General Meeting to Consider Issuance Mandate

Story Highlights
Jenscare Scientific Co., Ltd. Announces 2025 Extraordinary General Meeting to Consider Issuance Mandate

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ) has provided an announcement.

Jenscare Scientific Co., Ltd. has announced the convening of its 2025 second extraordinary general meeting, where a special resolution will be considered to grant the Board a general mandate for issuing convertible bonds and additional shares. This move is aimed at enhancing the company’s financial flexibility and market positioning, allowing it to respond effectively to market conditions and operational needs. The resolution, if approved, will enable the Board to issue up to 20% of the company’s shares, excluding treasury shares, under specific conditions and within a defined period, potentially impacting the company’s capital structure and shareholder value.

More about Jenscare Scientific Co. Ltd. Class H

Jenscare Scientific Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the scientific industry. The company is primarily focused on the development and provision of innovative scientific solutions, with a market focus that includes both domestic and international stakeholders.

Average Trading Volume: 1,034,270

Technical Sentiment Signal: Hold

Current Market Cap: HK$5.01B

For an in-depth examination of 9877 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1